<p>The government on Wednesday said that all seven manufacturers of Remdesivir in the country have been asked to ramp up production to full capacity by next week.</p>.<p>The direction comes against reports of shortages of the critical drug.</p>.<p>Remdesivir is considered a key antiviral drug in the fight against Covid-19, especially in adult patients with severe complications.</p>.<p>"There are seven players who produce Remdesivir. I have asked all players to ramp up production to full capacity by next week. The drug's API is manufactured in India so there won't be a problem," Mansukh Mandaviya, Minister of State for Chemical and Fertilizers, told PTI.</p>.<p>Mandaviya said these seven manufacturers - Mylan, Hetero, Jubiliant Life Sciences, Cipla, Dr Reddy's, Zydus Cadila and Sun Pharma - have a monthly production capacity of 31.60 lakh vials.</p>.<p>Letters have been despatched to all these drugmakers to ramp up production, he added.</p>.<p>Of the 31.60 lakh vials, Hetero produces 10.50 lakh vials a month, Cipla makes 6.20 lakh vials, 5 lakh vials are produced by Zydus Cadila and 4 lakh vials are produced by Mylan, Mandaviya said.</p>.<p>The remaining drugmakers produce vials in the range of 1 lakh and 2.5 lakh a month, he added.</p>.<p>The Madhya Pradesh government has decided to procure Remdesivir injections so that they could be provided free of cost for the treatment of critical COVID-19 patients from the economically weaker sections.</p>
<p>The government on Wednesday said that all seven manufacturers of Remdesivir in the country have been asked to ramp up production to full capacity by next week.</p>.<p>The direction comes against reports of shortages of the critical drug.</p>.<p>Remdesivir is considered a key antiviral drug in the fight against Covid-19, especially in adult patients with severe complications.</p>.<p>"There are seven players who produce Remdesivir. I have asked all players to ramp up production to full capacity by next week. The drug's API is manufactured in India so there won't be a problem," Mansukh Mandaviya, Minister of State for Chemical and Fertilizers, told PTI.</p>.<p>Mandaviya said these seven manufacturers - Mylan, Hetero, Jubiliant Life Sciences, Cipla, Dr Reddy's, Zydus Cadila and Sun Pharma - have a monthly production capacity of 31.60 lakh vials.</p>.<p>Letters have been despatched to all these drugmakers to ramp up production, he added.</p>.<p>Of the 31.60 lakh vials, Hetero produces 10.50 lakh vials a month, Cipla makes 6.20 lakh vials, 5 lakh vials are produced by Zydus Cadila and 4 lakh vials are produced by Mylan, Mandaviya said.</p>.<p>The remaining drugmakers produce vials in the range of 1 lakh and 2.5 lakh a month, he added.</p>.<p>The Madhya Pradesh government has decided to procure Remdesivir injections so that they could be provided free of cost for the treatment of critical COVID-19 patients from the economically weaker sections.</p>